x_label	specimen_descriptor_fill	box_sample_count	Gene_Ensembl_ID	Gene_symbol	PMTL	Dataset	Disease	GTEx_tissue_subgroup	EFO	MONDO	GTEx_tissue_subgroup_UBERON	TPM_mean	TPM_sd	TPM_min	TPM_25th_percentile	TPM_median	TPM_75th_percentile	TPM_max
Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)	Pediatric Primary Tumors	538	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TARGET	Acute Lymphoblastic Leukemia		EFO_0000220	MONDO_0004967		8.15	12.95	0.08	1.9	3.67	7.94	117.72
Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)	Pediatric Relapse Tumors	75	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TARGET	Acute Lymphoblastic Leukemia		EFO_0000220	MONDO_0004967		5.14	11.44	0.04	1.06	2.37	4.9	91.79
Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)	Pediatric Primary Tumors	168	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TARGET	Acute Myeloid Leukemia		EFO_0000222	MONDO_0018874		0.51	0.82	0	0.1	0.23	0.49	5.21
Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)	Pediatric Relapse Tumors	42	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TARGET	Acute Myeloid Leukemia		EFO_0000222	MONDO_0018874		0.43	0.35	0	0.19	0.36	0.52	1.41
Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 23)	Pediatric Primary Tumors	19	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Adamantinomatous Craniopharyngioma		EFO_1000069	MONDO_0002787		1.3	0.65	0.14	0.77	1.3	1.84	2.27
Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 23)	Pediatric Relapse Tumors	4	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Adamantinomatous Craniopharyngioma		EFO_1000069	MONDO_0002787		1.4	0.67	0.46	1.26	1.53	1.67	2.06
Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 30)	Pediatric Primary Tumors	24	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Atypical Teratoid Rhabdoid Tumor		EFO_1002008	MONDO_0020560		3.96	4.18	0.15	0.91	1.8	6.41	14.53
Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 30)	Pediatric Relapse Tumors	6	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Atypical Teratoid Rhabdoid Tumor		EFO_1002008	MONDO_0020560		3.66	4.65	0.7	1.08	1.66	3.62	12.82
CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)	Pediatric Primary Tumors	9	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	CNS Embryonal tumor		EFO_0005784	MONDO_0018843		28.94	22.79	2.25	14.75	21.78	50.91	64.13
CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)	Pediatric Relapse Tumors	4	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	CNS Embryonal tumor		EFO_0005784	MONDO_0018843		2.93	3.08	0.41	1.33	1.96	3.56	7.4
Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)	Pediatric Primary Tumors	10	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Craniopharyngioma		EFO_1000209	MONDO_0002787		0.48	0.32	0.16	0.26	0.41	0.57	1.21
Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)	Pediatric Relapse Tumors	3	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Craniopharyngioma		EFO_1000209	MONDO_0002787		4	6.52	0.17	0.23	0.3	5.91	11.52
Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 72)	Pediatric Primary Tumors	63	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Diffuse midline glioma		EFO_1000026	MONDO_0006033		8.21	9.44	0.36	2.37	4.97	10.11	59.85
Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 72)	Pediatric Relapse Tumors	9	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Diffuse midline glioma		EFO_1000026	MONDO_0006033		3.39	1.41	0.93	2.82	3.04	4.14	5.85
Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 23)	Pediatric Primary Tumors	18	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Dysembryoplastic neuroepithelial tumor		EFO_0005551	MONDO_0005505		4.13	3.18	0.47	1.06	4.14	7.08	9.24
Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 23)	Pediatric Relapse Tumors	5	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Dysembryoplastic neuroepithelial tumor		EFO_0005551	MONDO_0005505		6.68	2.94	4.18	5.25	5.96	6.25	11.74
Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)	Pediatric Primary Tumors	3	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Embryonal tumor with multilayer rosettes		MONDO_0016715	MONDO_0016715		54.85	13.69	39.83	48.96	58.09	62.37	66.64
Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)	Pediatric Relapse Tumors	3	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Embryonal tumor with multilayer rosettes		MONDO_0016715	MONDO_0016715		27.9	38.81	0.29	5.72	11.14	41.7	72.27
Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 88)	Pediatric Primary Tumors	69	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Ependymoma		EFO_1000028	MONDO_0016698		1.11	1.36	0.02	0.43	0.7	1.09	7.9
Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 88)	Pediatric Relapse Tumors	19	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Ependymoma		EFO_1000028	MONDO_0016698		2.02	1.4	0.32	0.77	1.76	3.28	4.61
Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 45)	Pediatric Primary Tumors	36	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Ganglioglioma		EFO_0003094	MONDO_0016733		2.04	1.68	0.46	0.94	1.27	2.76	6.68
Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 45)	Pediatric Relapse Tumors	9	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Ganglioglioma		EFO_0003094	MONDO_0016733		2.86	2.51	0.91	1.29	1.66	3.5	7.55
High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 122)	Pediatric Primary Tumors	89	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	High-grade glioma/astrocytoma		MONDO_0016680	MONDO_0016680		9.54	11.92	0.15	2.38	5.13	10.51	59.91
High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 122)	Pediatric Relapse Tumors	33	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	High-grade glioma/astrocytoma		MONDO_0016680	MONDO_0016680		11.07	27.33	0.41	0.73	2.97	6.74	135.87
Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 83)	Pediatric Primary Tumors	64	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Low-grade glioma/astrocytoma		MONDO_0016685	MONDO_0016685		2.92	2.25	0.28	1.33	2.59	3.87	12.52
Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 83)	Pediatric Relapse Tumors	19	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Low-grade glioma/astrocytoma		MONDO_0016685	MONDO_0016685		3.59	2.62	0.48	1.94	2.81	4.16	11.08
Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 118)	Pediatric Primary Tumors	105	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Medulloblastoma		EFO_0002939	MONDO_0007959		27.84	18.69	3.21	15.46	24.29	32.75	101.39
Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 118)	Pediatric Relapse Tumors	13	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Medulloblastoma		EFO_0002939	MONDO_0007959		22.18	13.47	1.74	15.61	20.66	29.32	51.3
Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 21)	Pediatric Primary Tumors	14	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Meningioma		Orphanet_2495	MONDO_0016642		0.68	0.5	0.16	0.39	0.58	0.78	2.03
Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 21)	Pediatric Relapse Tumors	7	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Meningioma		Orphanet_2495	MONDO_0016642		0.74	0.57	0.03	0.42	0.57	0.99	1.77
Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 315)	Pediatric Primary Tumors	303	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	All Cohorts	Neuroblastoma		EFO_0000621	MONDO_0005072		50.8	42.85	0.65	23.78	37.92	63.68	332.67
Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 315)	Pediatric Relapse Tumors	12	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	All Cohorts	Neuroblastoma		EFO_0000621	MONDO_0005072		46.08	43.21	0.27	16.03	37.52	58.66	132.41
Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)	Pediatric Primary Tumors	129	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TARGET	Neuroblastoma		EFO_0000621	MONDO_0005072		80.71	50.21	1.85	45.47	70.78	111.43	332.67
Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)	Pediatric Relapse Tumors	8	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TARGET	Neuroblastoma		EFO_0000621	MONDO_0005072		64.12	42.02	13.96	39.32	47.7	87.73	132.41
Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)	Pediatric Primary Tumors	10	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Neurofibroma/Plexiform		EFO_0000658	MONDO_0003304		0.45	0.26	0.08	0.26	0.41	0.6	0.94
Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)	Pediatric Relapse Tumors	6	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Neurofibroma/Plexiform		EFO_0000658	MONDO_0003304		0.56	0.59	0.08	0.16	0.34	0.7	1.65
Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 128)	Pediatric Primary Tumors	108	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Pilocytic astrocytoma		MONDO_0016691	MONDO_0016691		3.28	1.78	0.34	1.9	3.1	4.24	9.55
Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 128)	Pediatric Relapse Tumors	20	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Pilocytic astrocytoma		MONDO_0016691	MONDO_0016691		2.17	1.45	0.04	1.01	1.9	2.66	5.68
Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)	Pediatric Primary Tumors	124	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TARGET	Wilms tumor		MONDO_0006058	MONDO_0006058		6.44	3.57	0.2	3.48	6.14	8.78	17.93
Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)	Pediatric Relapse Tumors	5	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TARGET	Wilms tumor		MONDO_0006058	MONDO_0006058		6.36	3.06	2.28	4.93	5.83	9.29	9.49
Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 165)	TCGA Primary Tumors	152	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Glioblastoma Multiforme		EFO_0000519	MONDO_0018177		21	26.09	0.75	5.63	11.36	25.61	171.81
Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 165)	TCGA Relapse Tumors	13	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Glioblastoma Multiforme		EFO_0000519	MONDO_0018177		13.75	19.3	1.2	2.4	4.01	17.67	69.9
Low-grade glioma/astrocytoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 521)	TCGA Primary Tumors	507	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Low-grade glioma/astrocytoma		MONDO_0016685	MONDO_0016685		19.05	15.62	0.97	9.16	15.43	24.85	123.38
Low-grade glioma/astrocytoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 521)	TCGA Relapse Tumors	14	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Low-grade glioma/astrocytoma		MONDO_0016685	MONDO_0016685		32.02	32.05	4.4	13.83	24.12	34.48	129.29
Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 378)	TCGA Primary Tumors	373	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Ovarian Serous Cystadenocarcinoma		EFO_1000043	MONDO_0006046		3.07	4.6	0.11	0.8	1.6	3.31	44.87
Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 378)	TCGA Relapse Tumors	5	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Ovarian Serous Cystadenocarcinoma		EFO_1000043	MONDO_0006046		2.07	2.47	0.08	0.37	1.25	2.47	6.16
Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 261)	TCGA Primary Tumors	258	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Sarcoma		EFO_0000691	MONDO_0005089		4.86	6.28	0.15	1.35	2.63	5.95	51.12
Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 261)	TCGA Relapse Tumors	3	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Sarcoma		EFO_0000691	MONDO_0005089		1.74	1.13	1.02	1.08	1.15	2.09	3.04
